C3 Pancreatic Cancer Research Group

Improving the lives of persons diagnosed with pancreatic cancer by innovative research and clinical care.

Over the past several years, there has been a tremendous explosion in research activity around pancreatic cancer at UC San Diego, Sanford-Burnham Medical Research Institute and the Salk Institute. The C3- Pancreatic Cancer Research Group will build on the C3 collaborative agreement between UC San Diego Moores Cancer Center and the NCI basic cancer centers at Sanford-Burnham Medical Research Institute and the Salk Institute for Biological Studies.

Our mission is to unite scientists and clinicians committed to pancreatic cancer research and treatment in a highly collaborative environment that accelerates the progress and impact of our work.

We seek to stimulate team science and translational research collaborations in the pancreatic cancer space and:

  • More closely align basic and clinician researchers working in pancreatic cancer
  • Accelerate research and translation across campuses
  • Facilitate sharing of resources such as mouse models, cell lines, and tool compounds
  • Enable competitive large grant submissions and unique industrial collaborations
  • Attract new minds to the field from other research areas

Team Leaders

Andrew Lowy, MD

UC San Diego

Cosimo Commiso, PhD

Sanford Burnham

Pamela Itkin-Ansari

Sanford Burnham

Dannielle Engle

Salk Institute

C3 PCRG Events

​Monthly seminars are open to those from both academia and industry, interested in connecting with other investigators.

Program Contact:

Shirley Sarno

Regional Therapies Program Manager
Phone 858-246-0966​